Alerts will be sent to your verified email
Verify EmailPHARMAID
|
Pharmaids Pharma
|
Curis Lifesciences
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.42 % | 76.73 % | 9.47 % |
|
5yr average Equity Multiplier
|
1.31 | 1.91 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.18 | 1.07 | 1.46 |
|
5yr Avg Net Profit Margin
|
-26.11 % | 8.37 % | 4.57 % |
|
Price to Book
|
2.04 | 0.0 | 1.2 |
|
P/E
|
0.0 | 17.48 | 12.02 |
|
5yr Avg Cash Conversion Cycle
|
-124.59 Days | 45.79 Days | 5.37 Days |
|
Inventory Days
|
79.26 Days | 77.61 Days | 23.69 Days |
|
Days Receivable
|
54.5 Days | 65.45 Days | 65.58 Days |
|
Days Payable
|
383.86 Days | 245.93 Days | 89.52 Days |
|
5yr Average Interest Coverage Ratio
|
-741.3 | 5.43 | 17.08 |
|
5yr Avg ROCE
|
-21.3 % | 36.41 % | 13.68 % |
|
5yr Avg Operating Profit Margin
|
-35.99 % | 16.92 % | 10.7 % |
|
5 yr average Debt to Equity
|
0.16 | 0.12 | 0.05 |
|
5yr CAGR Net Profit
|
n/a | 65.64 % | 29.02 % |
|
5yr Average Return on Assets
|
-13.12 % | 9.21 % | 6.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.99 % | 68.03 % | 38.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
23.04 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Pharmaids Pharma
|
Curis Lifesciences
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|